Clinical trial
Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast…
NCT00429403 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00429403 |
|---|---|
| Title | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer |
| Official title | Phase III Randomized Study of a Goserelin Acetate for Preservation of Ovarian Function in Patients With Primary Breast Cancer (PBC) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Goserelin |
| Enrollment | 1 |
| Start date | Aug 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Jan 31, 2007 |
| Last update posted | May 9, 2016 |
| Countries | Japan, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: